Axial Biotech, Inc. Company Profile

14:21 EST 20th November 2017 | BioPortfolio

sAxial Biotech, Inc. is focused on the use of genetics and the development of minimally invasive, motion preserving implants to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is the first company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial product development initiative, Axial has made significant progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis. In addition, Axial’s founders have developed five fusionless surgical devices (including the only such device currently being implanted in humans) that have the promise of expanding the current treatable scoliosis patient population by a factor of ten. Axial intends to use its proprietary genetic intellectual property in the development of bio-mechanical devices, and to apply its gene discovery/product development methodology to other spinal diseases. Spine care has historically focused on ameliorating the pain and/or fixing structural damage after it occurs. Recent technological advances in minimally invasive surgical techniques and better instrumentation have made the spine industry the hottest segment of the medical device market today, according to Start-Up magazine. Market analysis indicates a $3 billion sales potential for new instrumentation alone within 4 years, with this market compounding at greater than 20% per year. In the last 24 months, over $250 million of reported venture capital financing has flowed into spine start-ups and investors have achieved exits totaling over $1 billion, including one IPO (NuVasive). Axial’s novel tests will complement the advances in surgical instrumentation by providing the spine care industry with the first to market diagnostic and prognostic tests for targeting earlier and more appropriate therapeutic interventions. Axial’s surgical devices, one of which is currently in off-label use in humans, represent the only available alternative to spine fusion in the treatment of scoliosis. Axial is located in Salt Lake City, Utah, a place the New York Times recently called “an ideal genetic laboratory.” (NYT, July 31, 2004 , page 1 )


2749 E. Parley’s Way, Suite 210
Salt Lake City
United States of America


Phone: 801-478-1650
Fax: 801-487-2477

News Articles [1629 Associated News Articles listed on BioPortfolio]

Axial Piston Hydraulic Motors and Pumps Market by Product Axial Piston Hydraulic Motors and Axial Piston Hydraulic Pumps and Application Manufacturing, Oil Gas, Agriculture, Automotive, Energy Utility, Mining, Food Beverages, Construction, Water Manage

An axial piston hydraulic motor is used to convert pressure and fluid energy into torque and angular displacement. An axial piston hydraulic pump, a type of positive displacement pump, is used to conv...

Axial Bio Names Rao Chief Medical Officer, Two Other VPs Appointed

Srinivas Rao has joined Boston-based Axial Biotherapeutics as chief medical officer. Prior to Axial, Rao was chief medical officer of Newark, CA-based Depomed (NASDAQ: DEPO). His experience includes e...

PsA scoring systems showed moderate sensitivity, high specificity in detecting change

The quantifying of radiographic axial psoriatic arthritis through currently available scoring systems has moderate sensitivity but high specificity for identifying true change, according to results.Re...

Obesity worsens physical function, QoL in axial spondyloarthropathy

SAN DIEGO — Patients with both obesity and axial spondyloarthropathy have higher disease activity, worse physical function and lower quality of life, according to data from a press release issued at...

Appointments: Almirall, Axial, Therachon, Theranexus, Carrick and Karolinksa

This week's roundup includes Almirall's appointment of a former Sanofi employee as CEO and various other high-level appointments by Axial...   

Axial Biotherapeutics Named a “Fierce 15” Biotech Company of 2017 by FierceBiotech

Axial Biotherapeutics, a biotechnology company building a unique class of microbial-targeted therapeutics for neurological diseases, today announced that it has been named by Fier...

MRI reveals sacroiliac inflammation in both healthy runners, patients with spondyloarthritis

SAN DIEGO — Although sacroiliac MRI has been extensively relied on to diagnose axial spondyloarthritis, research presented at the American College of Rheumatology Annual Meeting demonstrated that si...

VIDEO: Adalimumab appears effective in non-radiographic axial spondyloarthropathy

SAN DIEGO – Treatment with adalimumab led to remission and sustained disease control among patients with non-radiographic axial spondyloarthropathy, according to findings presented at the American C...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [281 Associated PubMed Articles listed on BioPortfolio]


Axial myopia is associated with elongation of the posterior ocular segment. The authors measured posterior fundus landmarks and assessed their associations with axial length.

Experimental Demonstration of a Sizeable Nonclassical CH···G Hydrogen Bond in Cyclohexane Derivatives: Stabilization of an Axial Cyano Group.

Base-catalyzed equilibration of anancomeric cyanocyclohexanes demonstrates that replacement of cis-3,5-dimethyl holding groups with electron-withdrawing CF3 groups dramatically increases the proportio...

Fibromyalgia is not axial spondyloarthritis: Towards an appropriate use of the ASAS classification criteria for axial SpA.

Axial spondyloarthritis classification criteria: the debate continues.

The Assessment of Spondyloarthritis International Society (ASAS) axial spondyloarthritis (axSpA) classification criteria marked a major step forward in SpA research, distinguishing axial from peripher...

Extra-axial tumors of the central nervous system.

Extra-axial tumors are intracranial neoplasms but are not located within the brain parenchyma. The localization of intracranial neoplasms helps to narrow down the possible differential diagnoses and a...

Clinical Trials [147 Associated Clinical Trials listed on BioPortfolio]

Study of the Efficacy and Safety of Secukinumab in Patients With Active Psoriatic Arthritis With Axial Skeleton Involvement

The purpose of this study is to demonstrate the efficacy and safety of secukinumab 150 mg or 300 mg in the management of axial manifestations in PsA patients who have failed to respond to ...

Study of Adalimumab in Subjects With Axial Spondyloarthritis

This study will study how well adalimumab works in the short and long term in people with axial spondyloarthritis who are not diagnosed as having either ankylosing spondylitis or psoriatic...

Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)

This is a not interventional, pragmatic, prospective, randomized (cluster) study to evaluate the potential benefit of a Treat to Target approach in comparison to routine treatment (i.e. us...

A Study of KHK4827 in Subjects With Axial Spondyloarthritis (axSpA)

To evaluate the efficacy of KHK4827 in axSpA (ankylosing spondylitis [AS] and non-radiographic axial spondyloarthritis [nr-axSpA]) subjects compared to placebo, as measured by the proporti...

Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis

The study is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of two dose regimens of certolizumab pegol (CZP) in subjects wit...

Companies [887 Associated Companies listed on BioPortfolio]

Axial Exchange Inc.

Axial Exchange, Inc. supports our national journey from fee-based to performance-based healthcare. The company’s products, Axial Provider and Axial Patient, enable con...

Axial Exchange, Inc.

Axial Exchange, Inc. supports our national journey from fee-based to performance-based healthcare. Our products enable continuity of care across disparate settings. When a ...

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics ...

Axial Exchange

Axial Exchange allows heath care systems of all types to share data in order to solve key clinical and business problems. Whether ensuring people can securely access their electronic health records ac...

Axial Biotech, Inc.

sAxial Biotech, Inc. is focused on the use of genetics and the development of minimally invasive, motion preserving implants to advance the diagnosis and treatment of diseases and deformities of the h...

More Information about "Axial Biotech, Inc." on BioPortfolio

We have published hundreds of Axial Biotech, Inc. news stories on BioPortfolio along with dozens of Axial Biotech, Inc. Clinical Trials and PubMed Articles about Axial Biotech, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Axial Biotech, Inc. Companies in our database. You can also find out about relevant Axial Biotech, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Corporate Database Quicklinks

Searches Linking to this Company Record